UK Stock Options Tax & HMRC Rules Guide

Stock options tax UK rules turn on one HMRC question: is your grant approved (EMI, CSOP, or SAYE) or unapproved under ITEPA 2003 Part 7? For most London tech employees at US-listed or late-stage companies, the answer is unapproved—meaning income tax (up to 45% in 2025/26) and National Insurance Contributions (NICs) hit the spread at exercise, not when Carta shows the grant. Qualifying EMI options at UK growth companies can defer all employment tax to a later capital gains tax (CGT) sale. RSUs follow a parallel path: taxed as earnings at delivery, not as investor capital gains.

Verified against HMRC ERSM110510, ETASSUM57010, and GOV.UK NI rates for 2025/26, accessed 1 August 2026. As of 6 April 2026, eligible companies may grant EMI under expanded limits (500 employees, £120m gross assets)—but grants before that date keep prior caps unless exercise-period extensions apply.

How HMRC classifies your equity: the decision that drives stock options tax UK

Enterprise Management Incentives (EMI) is a statutory UK scheme, not a generic startup label. Readily convertible assets (RCAs) are shares HMRC treats as easy to sell—almost all Nasdaq and LSE employer stock qualifies.

Methodology (1 August 2026): We mapped HMRC's employment-related securities chargeable events against ITEPA 2003 Part 7 and cross-checked PAYE on RCAs guidance in ERSM220060 for listed-company exercises.

Source: ETASSUM57010; ERSM110510

Pair this guide with the United Kingdom equity hub, EMI vs unapproved deep dive, and—if your employer is US-listed—US stock options in the UK.

EMI vs unapproved options: where most stock options tax UK liability appears

For qualifying EMI, HMRC's position is clear: exercise within the qualifying period with no disqualifying event produces no income tax or NIC if you pay at least the market value at grant (ETASSUM57010).

For unapproved options—including virtually all US parent-company ISO and NSO plans—the spread at exercise counts as employment income:

Gain = market value at exercise − strike price − deductible amounts

That gain runs through PAYE when shares are RCAs. Your employer should withhold income tax and employee NIC the same month you exercise.

Where I am less sure—anecdotally—private-company unapproved exercises without a liquid market may avoid employee NIC if HMRC accepts shares are not RCAs; your mileage will vary depending on whether a secondary price or buyback programme exists.

Position: For UK-native growth companies with proper EMI paperwork, protect qualifying status through exit—EMI is the right structure. For US Big Tech employees in London, ignore EMI entirely and model unapproved spread tax; your win is exercise timing and CGT annual exemption on the post-exercise leg.

RSU taxation under HMRC rules

Restricted Stock Units (RSUs) are not options—they are share acquisitions taxed under ITEPA Part 7 Chapter 4. The chargeable event is when you receive shares (or cash equivalent) and forfeiture risk ends.

PAYE withholding applies on RCA RSUs the same as option exercises. A single £150,000 vest can push you into the 40% band and trigger personal allowance taper above £100,000 income—budget effective rates above headline 20%.

Cross-read our comprehensive RSU guide for US parallels; UK timing differs from US W-2 Box 1 reporting.

National Insurance: the hidden layer on stock options tax UK

NIC is often overlooked until the exercise statement arrives. For 2025/26:

Employers frequently use a joint election to pass employer NIC to the employee on option gains. On a £80,000 spread, that pass-through alone can exceed £11,000—check your exercise confirmation before assuming sell-to-cover covers everything.

Source: GOV.UK National Insurance rates

Capital gains tax after exercise or vesting

Once you hold shares, further price rises are CGT, not employment income:

Your base cost for CGT equals the market value at exercise or vest (which includes any amount already taxed as employment income). Business Asset Disposal Relief (BADR) at 10% may apply to qualifying EMI share sales within the £1m lifetime limit—confirm current rates after each Budget.

Scottish taxpayers use Scottish income tax bands on employment income but UK-wide NIC and CGT rates on the non-savings slice.

Original research: stock options tax UK — liability on a £100,000 spread

Methodology (1 August 2026): We modelled a single exercise with £100,000 spread for a UK-resident employee in England/Wales/NI at 2025/26 rates, using ERSM110510 for unapproved gain and ETASSUM57010 for EMI. NIC assumes RCA treatment with employer NIC passed through via joint election. Figures are illustrative.

Named scenarios: two London employees, two HMRC outcomes

Tom — EMI at a Series B fintech (qualifying)

Take Tom, a staff engineer in Shoreditch granted 30,000 EMI options in January 2025 at £3.80 when HMRC agreed an EMI valuation of £3.80. The company has 140 employees and £38m gross assets—inside pre-2026 EMI limits. Tom exercises in July 2026 at £16.50 after a Series C (no disqualifying event).

• Spread at exercise: £381,000 economically—but £0 employment income under EMI.
• Cash needed for tax at exercise: Broker fees only—no PAYE sweep.
• On sale at £20: CGT on £3.50/share rise (~£105,000 gain)—BADR at 10% may apply if conditions met.

Aisha — RSUs and NSOs at a US-listed SaaS company

Take Aisha, a director of product at a Nasdaq-listed employer with a UK payroll entity. She receives 4,000 RSUs vesting at $52 (GBP/USD = 0.78) and holds 8,000 unapproved options at $18 she exercises at $52.

• RSU vest income: $208,000 → £162,240 employment income via PAYE.
• Option spread: $272,000 → £212,160 additional employment income.
• Combined cash tax: Likely 40–45% income tax band plus NIC on both events—sell-to-cover on the same day per ERSM220060.
• Later sale from $52 → $65: CGT only on the $13 post-acquisition appreciation; her base cost includes amounts already taxed.

Position: Tom should protect EMI qualifying status through any exit. Aisha should stagger RSU vests and option exercises across tax years where possible and model allowance taper above £100,000 total income—do not exercise options in the same month as a large RSU vest without running the numbers.

Steel-man: "My company said these are capital gains, not wages"

Best case for the argument: Your founder insists equity is "investment" not salary, the shares are in a holding company, and you signed a shareholders' agreement—so the spread should be CGT-only like buying shares on the open market.

Second steel-man: You exercised years after leaving and argue the gain relates to company growth, not employment services—the economic substance is investor return.

Rebuttal: HMRC taxes employment-related securities under ITEPA Part 7 based on the legal connection to employment, not economic labels. Options granted for services as an employee trigger earnings tax at exercise under ERSM110510 unless a specific statutory relief (EMI, CSOP) applies. Post-employment exercise does not recharacterise the gain—it may still be employment income of the exercise year. Pull the grant agreement and ERS return before accepting founder tax advice.

Decision guide: plan before you exercise

Working checklist

Verdict

For stock options tax UK, the approved vs unapproved fork separates zero employment tax at exercise (qualifying EMI) from a PAYE event that can consume more than half the spread once NIC pass-through lands. RSUs add a parallel employment-income charge at delivery. US-listed employees should read US options in the UK and ignore EMI labels that do not exist in their grant. UK growth-company employees with genuine EMI paperwork should protect qualifying status through exit and target BADR on sale—not chase ISO-style deferral that HMRC does not offer.

Footnotes

Disclaimer: This guide explains how HMRC commonly taxes stock options, RSUs, and related employment securities for UK-resident employees. It is not personalized tax, legal, or financial advice. UK rules change frequently—especially EMI limits from 6 April 2026. Always consult a qualified UK tax adviser before exercising, vesting, or selling.

Primary Sources

Last Updated: 1 August 2026 | Research Team: VestingStrategy